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To define the role of the surface lipooligosaccharide (LOS) of Haemophilus ducreyi in the pathogenesis of
chancroid, Tn916 mutants of H. ducreyi 35000 defective in expression of the murine monoclonal antibody (MAb)
3F11 epitope on H. ducreyi LOS were identified by immunologic screening. One mutant, designated 1381, has
an LOS which lacks the MAb 3F11 epitope and migrates with an increased mobility on sodium dodecyl sulfatepolyacrylamide gel electrophoresis. The gene disrupted by the Tn916 element in strain 1381 was identified by
cloning the sequences flanking the Tn916 element. The sequences were then used to probe a lDASHII genomic
library. In strain 1381, Tn916 interrupts a gene which encodes an open reading frame (ORF) with an Mr of
40,246. This ORF has homology to the product of the rfaK gene of Escherichia coli. The major LOS glycoform
produced by strain 1381 was analyzed by using a combination of mass spectrometry, linkage and composition
analysis, and 1H nuclear magnetic resonance spectroscopy. The major LOS species was found to terminate in
a single glucose attached to the heptose (L-glycero-D-manno-heptose, or Hep) trisaccharide core. In the wild-type
strain 35000, glucose serves as the acceptor for the addition of the D-glycero-D-manno-heptose (or DDHep), which
extends to form the mature branch of the H. ducreyi LOS. This mature oligosaccharide is in turn partially
capped by the addition of sialic acid (NeuAc), i.e., NeuAc2a33Galb134GlcNAcb133Galb134DDHepa13
6Glcb1 (W. Melaugh et al., Biochemistry 33:13070–13078, 1994). Since this LOS terminates prior to the
addition of the branch DD-heptose, this gene is likely to encode the D-glycero-D-manno-heptosyltransferase.
Strain 1381 exhibits a significant reduction in adherence to and invasion of primary human keratinocytes. This
defect was complemented by the cloned heptosyltransferase gene, indicating that the terminal portion of the
LOS oligosaccharide plays an important role in adherence to human keratinocytes.
viously reported to be produced by Campylobacter jejuni and
certain Escherichia coli strains (11).
The lipooligosaccharides (LOS) of H. ducreyi have also been
implicated as important virulence factors. Several studies have
demonstrated that H. ducreyi LOS cause ulcers in rabbits and
mice (9, 21, 55). Recent structural studies have begun to define
the LOS glycoforms expressed by several different H. ducreyi
strains, including strains 35000, ITM5535, ITM3147, and
ACY1 (27, 29, 45). In addition, recent data have demonstrated
that the principal LOS glycoform expressed by most H. ducreyi
strains is highly sialylated on the terminal galactose residue of
N-acetyllactosamine in a manner similar to that previously
reported for Neisseria gonorrhoeae (27; reviewed in reference
39). A recent in vitro study used extremely high concentrations
of LOS isolated from strain 35000 to inhibit the adherence of
these bacteria to human foreskin fibroblasts, indirectly suggesting a role of the LOS in adherence (3).
To better understand the role of LOS in the pathogenesis of
chancroid, we have begun to characterize defined mutations in
the biosynthetic pathway for H. ducreyi LOS (8). In this report,
we have characterized a Tn916 mutant of strain 35000 which
produces an LOS which lacks DD-heptose and the subsequent
sugar residues distal to this heptose. This LOS mutant exhibits
a markedly reduced ability to adhere to human keratinocytes
compared to the parent strain. These data directly implicate

Haemophilus ducreyi is one of the causative agents of genital
ulcer disease, which is prevalent in many developing countries
(1, 30, 43). More importantly, it has been shown that H. ducreyi
infection facilitates the heterosexual transmission of the human immunodeficiency virus (HIV), particularly in geographic
areas where both diseases are prominent (16, 19, 53, 58). Because of the association between H. ducreyi infection and HIV
transmission, the identification of specific bacterial factors
which contribute to the pathogenesis of chancroid is important.
Although the mechanisms of virulence are not well understood, putative virulence determinants have recently been
identified and characterized. In 1992, Alfa reported that H.
ducreyi produced a cell-associated cytotoxin (2). This cytotoxin
has now been identified as a homolog of the hemolysins produced by Serratia marcescens and Proteus mirabilis (32, 54).
Mutants deficient in cytotoxin expression have been generated;
these mutants fail to kill human foreskin fibroblasts in culture
(4, 31). Purven and Largergard identified a secreted toxin
which kills epithelial cells (40). This toxin has recently been
identified as a homolog of the cytolethal distending toxin pre-
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FIG. 1. Silver-stained SDS-polyacrylamide gel of LOS preparations from H.
ducreyi 35000 (lane 1) and 1381 (lane 2). The murine MAb 3F11 binding glycoform is marked with the arrow.

the terminal oligosaccharide region of H. ducreyi LOS as an
important ligand in attachment to human keratinocytes, which
are most likely the first cell type encountered by the bacterium
during the early stages of infection.
MATERIALS AND METHODS
Materials. Sodium borodeuteride (98% D) and 2,5-dihydroxybenzoic acid
were purchased from Aldrich (Milwaukee, Wis.). Acetonitrile, water, and methanol were obtained from Burdick and Jackson (Muskegon, Mich.). Acetic anhydride was purchased from Supelco (Bellefonte, Pa.), and methyliodide was obtained from Fluka (Switzerland). All other reagents and solvents used were of
reagent grade.
Bacterial strains and culture conditions. H. ducreyi 35000 was grown at 35°C
with 5% CO2 on chocolate agar (Becton Dickinson). Chocolate agar plates which
were supplemented with antibiotics were prepared with BBL GCII agar base,
IsoVitaleX, and hemoglobin according to the manufacturer’s instructions. Plates
were supplemented with tetracycline at 5 mg/ml or kanamycin at 10 mg/ml as
appropriate. E. coli strains were grown in Luria-Bertani (LB) plates or in LB
broth supplemented with antibiotics as appropriate.
Recombinant DNA methods. Standard recombinant DNA methods were used
as described previously (24, 48) or as specified by the manufacturers. The construction of the lDASHII genomic library was described previously (32). The
shuttle vector pLS88 was described by Willson et al. (59), and the pSC101-based
vector pWKS30 was constructed by Wang and Kushner (57). Plasmids pSuperCos I and pCRII were obtained from Stratagene (La Jolla, Calif.) and Invitrogen
(San Diego, Calif.), respectively. Tn916 mutagenesis was performed by using
pAM120 as described previously (32). DNA sequence was determined in both
directions, using Sequenase (U.S. Biochemical Corp.) according to the manufacturer’s directions. Contig assembly and sequence analysis were performed
with the Lasergene software (DNASTAR, Madison, Wis.). Homology determinations and sequence alignment were performed with the NCBI BLAST server
and with the GAP program from the Wisconsin sequence analysis package
(Genetics Computer Group, Madison, Wis.).
Preparation and analysis of LOS. LOS from each H. ducreyi strain was prepared by a modification of the microphenol method previously described (9).
The LOS preparations were analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) on a 14% acrylamide gel as previously reported (9).
Immunologic screening. Screening for LOS mutants in the H. ducreyi Tn916
library was performed by using a colony lift assay. Ten 150- by 15-mm chocolate
plates containing approximately 10,000 tetracycline-resistant H. ducreyi colonies
were screened. Colonies were lifted from 24-h-old plates onto nitrocellulose
filters, which were then blocked with 3% bovine serum albumin. The culture
plates were returned to the incubator to allow the colonies to regrow. The filters
were incubated for 1 h with monoclonal antibody (MAb) 3B9, which recognizes
a surface-exposed epitope on a 18-kDa outer membrane protein of H. ducreyi
(49). This epitope phase varies at a rate of less than 1:104 colonies. MAb 3B9
bound to the colonies was detected with a goat anti-mouse immunoglobulin
G-phosphatase conjugate (Kirkegaard & Perry, Gaithersburg, Md.). The filter
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was developed with fast red TR/naphthol AS-MX (Sigma Chemical Company,
St. Louis, Mo.). The same filters were washed in Tris-buffered saline (50 mM
Tris, 100 mM NaCl [pH 7.0]) and then incubated overnight with MAb 3F11. 3F11
binding to the colonies was detected by using a goat anti-mouse immunoglobulin
M-peroxidase conjugate (Kirkegaard & Perry). The filters were developed with
horseradish peroxidase reagent (Bio-Rad, Richmond, Calif.). The filters were
washed in Tris-buffered saline after color development was completed. Colonies
which bound both 3B9 and 3F11 stained purple, while those which bound only
3B9 stained red. Survey of the 10 filters revealed seven colonies which bound
only MAb 3B9.
Preparation of LOS and LOS-derived oligosaccharides. LOS was prepared
from H. ducreyi 35000 and 1381 by using a phenol-water extraction procedure as
described by Apicella et al. (5). LOS was O-deacylated by treatment with hydrazine under mild conditions (37°C, 30 min) followed by precipitation with chilled
acetone. An oligosaccharide fraction was generated from approximately 1 mg of
intact LOS by mild acid hydrolysis in 1% acetic acid for 2 h at 100°C. The
released oligosaccharide pool was then separated from the largely insoluble lipid
A by centrifugation (5,000 3 g, 20 min at 4°C) and lyophilized. The lyophilized
oligosaccharide pool was further purified and desalted by gel filtration chromatography on a Bio-Rad SEC column, with the eluent monitored by refractive
index. The single broad peak obtained from the strain 1381 preparation was
pooled and lyophilized. Details of all these procedures have been published
elsewhere (29, 36).
Composition and methylation analysis. To determine the composition and
linkages of the individual sugars in the mutant LOS, the oligosaccharide pool was
first analyzed for monosaccharides after hydrolysis in 2 M trifluoroacetic acid for
3 h at 100°C. The hydrolysates were evaporated to dryness, redissolved in 20 ml
of H2O, and dried. Monosaccharide separation and quantitation were carried out
by high-pH anion-exchange chromatography with pulsed amperometric detection (36). For linkage analysis, approximately 50 mg of the total oligosaccharide
fraction was subjected to permethylation, using a modification of the technique
of Levery and Hakomori (23). The partially methylated alditol acetates were
analyzed by gas chromatography (GC)-mass spectrometry (MS) using a VG70SE
mass spectrometer equipped with a Hewlett-Packard 5890 gas chromatograph
equipped with a 30-m DB-1 column (J&W Scientific).
MS. To determine the molecular masses and compositions of LOS from strain
1381, the acid-released oligosaccharide pool and O-deacylated LOS were analyzed by liquid secondary ion MS (LSIMS), electrospray ionization (ESI)-MS,
and matrix-assisted laser desorption ionization (MALDI). These methods as
applied to the analysis of LOS have been described in detail elsewhere (12, 13,
28). For LSIMS analysis, a thioglycerol-glycerol (1/2, vol/vol) matrix was used,
and samples were mass analyzed on a Kratos MS 50S mass spectrometer (Kratos,
Manchester, England). A primary ion beam of 10 keV was used to ionize the
samples, and secondary ions were accelerated at 6 kV. Scans were acquired at
300 s/decade and recorded on a Gould electrostatic recorder. Ultramark 1206
was used for manual calibration to an accuracy better than 60.2 Da. For ESI-MS
analysis, a Platform quadrupole mass spectrometer (MicroMass, Manchester,
England) in the negative-ion mode was used. Samples were first dissolved in
water and then injected (3-ml aliquot, '5 mg) via a Rheodyne injector into a
constant stream of H2O-CH3CN (3/1, vol/vol) containing 1% acetic acid running
at 3 to 4 ml/min. Mass calibration was carried out with an external cesium nitrate
reference, using the supplied commercial software. For MALDI analysis of
O-deacylated LOS, ca. 0.2 mg of sample was dissolved in 1 to 2 ml of acetonitrilewater and mixed with an equal volume of 100 mM 2,5-dihydroxybenzoin acid.
One microliter of this sample-matrix solution was dried on the MALDI probe at
room temperature and analyzed with a PerSeptive Biosystems (Framingham,
Mass.) Voyager MALDI time-of-flight (MALDI-TOF) mass spectrometer
equipped with a nitrogen laser (337 nm) and run in the negative-ion mode with
delayed extraction (56). The resulting spectra were calibrated with an external
reference consisting of the peptides angiotensin (Mr 5 1,296.5) and adrenocorticotropin (Mr 5 2,465.7).
NMR analysis. 1H nuclear magnetic resonance (NMR) analyses of the highpressure liquid chromatography-purified oligosaccharide fraction from strain
1381 were carried out to determine the anomeric configurations of the sugars

TABLE 1. Composition and methylation analysis of strain 35000 and strain 1381 oligosaccharides
Composition analysisa (molar ratio relative to glucose)
Strain

35000
1381
a

b

Methylation analysisd (relative peak area)

Galactose

Glucose

LD-Heptose

DD-Heptose

GlcNH2

t-Gal

3-Gal

x-Glce

t-Hep

2-Hep

3,4-Hep

4-Hep

4-GlcNAc

2.5

1.0
1.0

2.7
2.3c

0.8

1.1

1.0

1.5

1.7
1.0

0.7
1.1

0.9
0.5

0.7
0.5

0.6

1.8

Composition and methylation data for the parental strain 35000 have been previously published (28) and are reported here for comparative purposes only.
This second heptose has been identified as D-glycero-D-manno-heptose, as opposed to the major core heptoses, which are L-glycero-D-manno-heptoses.
The lower than expected relative molar ratios for heptose compared to glucose are partially explained by background contamination of glucose.
d
Partially methylated alditol acetates are abbreviated according to their substitution pattern as follows: t-Gal is 1,5-di-O-acetyl-2,3,4,6-tetra-O-methylgalactitol, 3-Gal
is 1,3,5-tri-O-acetyl-2,4,6-tri-O-methylgalactitol, etc.
e
6-Glc was observed in strain 35000, and terminal glucose (t-Glc) was observed in strain 1381.
b
c
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FIG. 2. Negative-ion ESI-MS spectrum of acid-cleaved oligosaccharide fraction of H. ducreyi 1381 LOS. The peaks associated with the major oligosaccharide are
labeled with asterisks and are observed as two single charged species at (M 2 H)2 5 957.4 and (M 2 H 1 H2O)2 5 975.4 with an average mass of 958.4 Da. Note
the small amount of wild-type oligosaccharide peaks with Mrs of 1,678.7 (m/z 838.2 and 1,677.7; ■) and 1,516.4 (m/z 757.2 and 1,515.2; å) corresponding to doubly and
singly charged species. Also observed is a fourth component with an Mr of 1,486.2 (m/z 742.1 and 1,485.1; F) that would nominally correspond to an oligosaccharide
containing one less heptose (DM 5 192.2 Da) than the 1678.7-Mr oligosaccharide. See text and Table 2 for details.

and to confirm the linkage assignments. For these experiments, approximately
100 mg of oligosaccharide was analyzed on a GE GN-500 MHz NMR apparatus
under conditions identical to those originally reported for the NMR characterization of the major oligosaccharide from the parent strain, H. ducreyi 35000 (29).
Adherence and invasion of human keratinocytes. The isolation of human
keratinocytes and preparation of monolayers have been described elsewhere (7).

In addition, we used the standard adherence assay conditions, including the
preparation of bacterial inocula, described by Brentjens et al. (7). H. ducreyi
invasion of keratinocytes was assessed by using the gentamicin protection assay
described by St. Geme and Falkow (52). Briefly, the standard adherence assay
was performed in duplicate plates as described previously (7). One plate was
processed to measure adherence, and gentamicin sulfate (35 mg/ml) was added

TABLE 2. ESI-MS analyses of O-deacylated LOS and oligosaccharides from strain 1381a
Sugars

O-deacylated LOS

Oligosaccharides

a

Mr

Form

b

Observed

Calculated

A9
A
A0
B9
B
B0

1,974.0
1,991.0
2,006.0
2,097.2
2,115.4
2,130.0

1,973.8
1,991.8

A
A
A
A

958.4
1,486.2
1,516.4
1,678.7

2,096.8
2,114.8
958.8
1,486.3
1,516.3
1,678.5

Relative
abundance
(%)

Proposed composition

94
80
72
100
98
81

Hex Hep3 Kdo(P) lipid Ac; 2H2O
Hex Hep3 Kdo(P) lipid A
Hex Hep3 Kdo(P) lipid A; 114 Da
Hex Hep3 Kdo(P) PEA lipid A; 2H2O
Hex Hep3 Kdo(P) PEA lipid A
Hex Hep3 Kdo(P) PEA lipid A; 114 Da

100
9
13
28

Hex Hep3 anhydro-Kdo
Hex3 HexNAc Hep3 anhydro-Kdo
Hex2 HexNAc Hep4 anhydro-Kdo
Hex3 HexNAc Hep4 anhydro-Kdo

The major unmodified O-deacylated LOS glycoforms are indicated by the boldface type.
All molecular weights for O-deacylated LOS are reported as average values based on both doubly and triply deprotonated charged molecular ions, (M 2 2H)22
and (M 2 3H)32, with the exception of the 2,130-Mr species, whose doubly charged ion was unresolved from the sodiated adduct of the 2,115-Mr LOS. For the
oligosaccharides, molecular weights are based on singly and doubly charged ions, (M 2 H)2 and (M 2 2H)22, with the exception of the 958.4-Mr species, which yielded
only a singly charged peak.
c
After O-deacylation, the lipid A moiety is converted into diphosphoryl diacyl-lipid A containing two N-linked b-hydroxymyristic acid chains with an average Mr of
953.0. In the LOS species containing PEA, preliminary data indicate that it is attached to one of the two phosphates on lipid A.
b
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FIG. 3. Negative-ion ESI-MS spectrum of O-deacylated LOS from H. ducreyi 1381. The inset (top left) shows the corresponding LSIMS spectrum of the molecular
ion region taken at higher resolving power. In the ESI-MS spectrum, the LOS-A and -B glycoforms have two additional peaks arising from either loss of H2O, (M 2
nH 2 H2O)n2, or the addition of an unknown adduct with a mass difference of 14 to 15 Da (or 32 to 33 Da from the LOS peaks that have lost H2O). Note that these
latter peaks at m/z 667.6, 709.0, 1,002.1, and 1,064 (all marked by asterisks) do not appear in the LSIMS or MALDI spectra, suggesting they are artifacts of the ESI-MS
experiment. The higher-mass LOS-B species contains a PEA moiety which is likely present linked to phosphate to form a phospho-PEA moiety in the lipid A region.
The presence of an internal pyrophosphate linkage in the LOS species containing this additional PEA moiety accounts for the additional salt adducts in the ESI-MS
spectrum, including sodium, potassium, and iron, as well as dominance of the sodiated adduct for this same species in the LSIMS spectrum. After summing the area
of all related peaks for the LOS-A and LOS-B glycoforms, a ratio of 1 to 3 (A to B) is obtained. Small amount of a third LOS species (LOS-C) can be seen as
subsequently confirmed in the MALDI spectrum (Fig. 4), as well as a triply charged ion for the major wild-type LOS glycoform at m/z 902.7. See Table 2 for the
assignments of LOS composition.

to each well of the duplicate plate. This plate was allowed to incubate for an
additional 2 h at 37°C. After extensive washing, the keratinocytes were lysed, and
the suspension diluted and then plated out in triplicate on chocolate agar.
Percent invasion was assessed by determination of CFU.
Nucleotide sequence accession number. The DNA sequence of the losAB
region is available through GenBank (accession no. AF004712).

RESULTS
Identification of Tn916 mutants deficient in LOS biosynthesis. A library of Tn916 mutants was generated by electroporation of pAM120 into H. ducreyi 35000 as described previously
(32). Seven mutants which failed to bind MAb 3F11 were
characterized. A LOS preparation from each strain was analyzed by SDS-PAGE. The LOS from strain 1381 ran with the
highest mobility on SDS-PAGE compared to preparations
from strain 35000 and the other Tn916 LOS mutants. A silverstained SDS-polyacrylamide gel comparing the mobilities of
the LOS from strains 35000 and 1381 is shown in Fig. 1. The
LOS from strain 1381 and the mutation responsible for this
phenotype were further characterized.
Structural characterization of strain 1381 LOS. For the structural characterization of LOS, a crude LOS preparation was
isolated and an oligosaccharide fraction was prepared by acetic

acid hydrolysis. The structure of the oligosaccharide portion of
the LOS from strain 1381 was investigated by using MS, composition and linkage analysis, and 1H NMR data. On the purified oligosaccharide fraction, composition analysis showed
only two types of sugars present, heptose and glucose, in a
molar ratio of 2.3 to 1 (Table 1). GC-MS of the partially permethylated alditol acetates established the presence of four
sugars: a terminal glucose and terminal heptose, a 2-linked
heptose, and a 3,4-linked heptose. The absence of 2-keto-3-deoxyoctulosonic acid (Kdo) was expected due to the conversion
of the presumed 4-phospho-Kdo sugar to the anhydro-Kdo
products during the mild-acid step (6) as reported previously
for several Haemophilus species (34, 35, 45, 46), including the
LOS from the parental H. ducreyi 35000 (28, 29). These reducing terminal anhydro-Kdo diastereomers are presumably destroyed during the acid hydrolysis conditions used in the
monosaccharide analysis.
To determine the masses and assign a precise composition to
the oligosaccharide region from the LOS of strain 1381, the
acid-cleaved oligosaccharide fraction was analyzed by both
LSIMS and ESI-MS after size-exclusion chromatography. The
ESI-MS spectrum for the oligosaccharide fraction is shown in
Fig. 2; the data are summarized in Table 2. In both cases, the
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FIG. 4. Negative-ion MALDI-TOF spectrum of O-deacylated LOS from H. ducreyi 1381. The intact O-deacylated LOS-A, -B, and -C glycoforms are observed in
their deprotonated ionic states, (M 2 H)2, as well as several cationized states, (M 2 2H 1 Na)2 (*), (M 2 3H 1 2Na)2 (■), (M 2 4H 1 3Na)2 (F), and (M 2 5H 1
4Na)2 (å). Lipid A9(P)2 refers to the diphosphorylated O-deacylated form. See Fig. 5 and the text for more details.

major peak observed corresponded to a common oligosaccharide with an isotopically resolved mass of 958.2 (LSIMS) and
an average mass of 958.4 (ESI-MS). (The higher resolving
power of the sector instrument under LSIMS conditions
yielded isotopically resolved peaks, with the most abundant
peak isotopically pure [exact mass]. The ESI-MS experiment
was carried out with a quadrupole analyzer which did not
resolve these isotopes and whose centroid is the average mass.)
These data compare well with a calculated exact mass of 958.3
and an average mass of 958.8 for an oligosaccharide consisting
of one hexose, three heptoses, and one anhydro-Kdo as expected from the composition and linkage analysis data. In
addition to this major oligosaccharide peak, we observed in the
ESI-MS spectrum several smaller peaks that have been previously identified as belonging to full-length wild-type oligosaccharide structures (28, 29), such as the 1679- and 1516-Mr
oligosaccharide species (singly and doubly charged ions at m/z
1,677.7 and 838.2 and at m/z 1,515.2 and 757.2, respectively).
These two full-length oligosaccharides correspond in mass to
oligosaccharides with Galb1-4GlcNAcb1-3Galb1-4DDHepa16Glcb1 and GlcNAcb1-3Galb1-4DDHepa1-6Glc branches attached to the Hep3-anhydro-Kdo core structure. These latter
structures apparently arose from some reversion of the strain
1381 mutant back to the parental wild-type strain. Excision of
the Tn916 element is known to occur, resulting in the restoration of the parental genotype (47). A third, low-abundance
oligosaccharide with a mass of 1,486 Da was also present in this
oligosaccharide fraction, as evident from the presence of both
singly charged and doubly charged ions at m/z 1,485.1 and
742.1, respectively. This oligosaccharide was not observed in
our previous work on this parental strain despite it having a

mass within the expected range of full-length wild-type structures (28, 29). Computer composition searches based on this
experimental mass suggest that it differs from the previously
determined full-length wild-type oligosaccharide (Mr 5 1,678)
by the absence of a single heptose residue (DM 5 192 Da,
heptose). Although this novel species could arise from the
absence of a LD-heptose from the triheptose core, it is more
likely that is originates from an alternative biosynthetic pathway that bypasses the addition of the branch DD-heptose. This
point will be discussed later.
In contrast to the relative simplicity of the oligosaccharide
MS data, analysis of the O-deacylated LOS yielded a far more
complex spectrum than would have been expected from a LOS
containing a single major oligosaccharide. Under ESI-MS conditions, we observed two major LOS glycoforms with average
molecular weights of 1,991.6 (LOS-A) and 2,115.4 (LOS-B)
(Fig. 3). Similarly, LSIMS analysis also indicated two major
isotopically resolved LOS species at the same mass, although
the higher-mass LOS-B was present primarily in a sodiated
form (Fig. 3, inset). The lower-mass LOS-A glycoform is in
excellent agreement with the oligosaccharide data after addition of the mass of diphosphoryl diacyl-lipid A moiety (DM 5
934 Da) and correcting for the mass difference between anhydro-Kdo and phospho-Kdo, i.e., Mr average is 1,991.8 and Mr
exact is 1,990.8 for the O-deacylated LOS-A species. The higher-mass peaks that belong to the second LOS-B glycoform,
however, differ by the mass of phosphoethanolamine (PEA;
DM 5123 Da), a moiety not observed in MS data of the oligosaccharide fraction. In addition, a third LOS species (LOSC) was tentatively identified as possibly containing two PEA
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common to most LOS-derived oligosaccharide fragments containing an unsubstituted phosphate (12). The absence of the
loss of phosphoric acid suggests that it is the phosphate of
phospho-Kdo that is substituted with PEA. Substitution of
phosphate by PEA at this position would also explain the
absence of PEA in the acid-cleaved oligosaccharide fraction as
observed in the ESI-MS spectrum (Fig. 2). If PEA were substituted on the phosphate of phospho-Kdo, acid-catalyzed belimination of phosphate to form anhydro-Kdo would eliminate the PEA group as well.
Similarly, partial substitution of PEA is also evident in the
lipid A moiety. Examination of the lower-mass region of this
same MALDI spectrum shows the base peak of m/z 952 (and
the sodiated adduct at m/z 974) for the expected lipid A fragment containing two N-linked b-hydroxymyristic acid groups
and two phosphates. However, a second set of peaks ;123 Da
higher in mass is also present at m/z 1,075 and 1,097, at ;50%
relative abundance, providing evidence for the partial substitution of lipid A by PEA. Therefore, based in part on the
wild-type oligosaccharide structure from the parental strain
35000, these data support a major LOS structure with a single
glucose attached to a Hep3Kdo(P) core where phospho-Kdo is
largely (;80%) modified by PEA to form phospho-PEA and
where the lipid A is partially (;33%) substituted with PEA:

FIG. 5. Structures and masses of the molecular ions and fragments predicted
from the negative-ion MALDI spectrum of O-deacylated LOS. See Fig. 4 for the
experimentally determined masses. The position of the variable PEA on lipid A
has not been determined.

moieties, but their precise masses could not be unambiguously
assigned due to extensive salt adducts and low ion abundance.
To examine the source of the PEA substitution(s) and confirm the presence of the third LOS species (LOS-C), this same
O-deacylated LOS preparation was analyzed by MALDI-TOF
MS. When the LOS was analyzed by MALDI, we previously
reported that masses are observed for both the intact LOS
glycoforms as well as fragments arising from the oligosaccharide and lipid A moieties (12). As shown in Fig. 4, MALDI
data obtained from this LOS preparation revealed three LOS
glycoforms, LOS-A, -B, and -C, with molecular weights of
1,990.5, 2,114.8, and 2,236.5. The masses of LOS-A and -B
were consistent with those previously observed by LSIMS and
ESI-MS. The third glycoform, LOS-C, has a mass consistent
with the presence of two PEA moieties compared to LOS-A,
which therefore confirms the tentative assignment made from
the ESI-MS spectrum (Fig. 3). In addition, fragments originating from these LOS species through glycosidic bond cleavage
were identified at m/z 1,161 and 1,117. This latter finding is
consistent with an oligosaccharide fragment having a composition of GlcHep3Kdo(P)PEA [Kdo(P) is phospho-Kdo], where
the lower-mass fragment has lost CO2 from Kdo through a
subsequent fragmentation process (244 Da) (Fig. 5). Two
analogous oligosaccharide fragments that do not have this
PEA moiety are also present but are only about half as abundant (see peaks at m/z 1,038 and 994). These oligosaccharide
fragments, therefore, clearly show that the majority of the
LOS-derived oligosaccharides contain one PEA moiety. Moreover, unlike oligosaccharide fragments that have an unsubstituted phosphate group on the Kdo (49-phospho-Kdo), the
PEA-containing oligosaccharide species do not undergo loss of
phosphoric acid (2H3PO4), a MALDI fragmentation pathway

Glc33y4Hep13Kdo~P!3lipid A~P!2~PEA!0–1
3y4
1
1
~PEA!0–1
Hep132Hep1
To confirm the oligosaccharide portion of the strain 1381
LOS structure and to assign linkage and anomeric configurations, proton NMR analysis was carried out on a 100-mg sample of the acetic acid-released oligosaccharide. As summarized
in Fig. 6, we found anomeric proton resonances that were
consistent with those previously assigned as three alpha-linked
heptoses and one beta-linked glucose in the H. ducreyi wildtype structure (29, 46) as well as the analogous structure found
in Haemophilus influenzae 2019 LOS (34). As described for
those systems, the anomeric proton of spin system III (nonreducing terminal heptose) was least effected by the multiplicity

FIG. 6. Anomeric proton NMR assignments of the major oligosaccharide
from H. ducreyi 1381 (D2O, 25°C). Shown are chemical shifts and coupling
constants obtained from the one-dimensional spectrum. *, average of overlapping signals arising from reducing-terminal microheterogeneity.
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TABLE 3. Oligonucleotides used in this study
No.

Sequence

Comment

1
2

59CGTGAAGTATCTTCCTACAG
59GCTACTAAATTATGCGTATC
CTATTCG
59GGGAATTCCCCTTGCGTTTT
TGGTG
59GCGAGCTCCCTATTTGGGC
AGTATT

Tn916 left end
Used for generating probe

3
4

59 of losB, EcoRI site at
59 end is underlined
39 of losB, SacI site at the
59 end is underlined

of isomers present in the reducing terminal anhydro-Kdo moiety and was seen as a single broad peak (d 5.112, J1,2 ,1 Hz).
The anomeric protons of the other two heptose spin systems, II
and I, were each seen as three peaks (Fig. 6) due to their
proximity to the heterogeneous reducing terminus. Based on
the similarity of these peaks to the spectrum of the wild-type
structure, heptoses I, II, and III were all assigned as alpha
linked. The remaining high-field-shifted anomeric proton
could be assigned as a beta-linked glucose and, like the heptose
I and II spin systems, was perturbed by the anhydro-Kdo into
three overlapping peaks (d '4.52, J1,2 '7 to 8). Therefore,
when combined with the composition, linkage, and MS data,
these NMR assignments support a pentasaccharide structure
identical to that contained within the parental 35000 strain:
Glcb134Hepa13anhydro-Kdo
3
1
Hepa132Hepa1
Identification of the gene interrupted by Tn916 in strain
1381. Genomic DNA from strain 1381 was prepared, partially
digested with Sau3A, and ligated into the cosmid vector
pSuperCos I. The library was packaged in vitro and transduced
into E. coli x2819 (10). Clones resistant to ampicillin (plasmid
marker) and tetracycline (Tn916 marker) were identified. Plasmid DNA was prepared, and the sequence was determined
from one cosmid clone by using an oligonucleotide primer
which recognizes the end of Tn916 (Table 3, oligonucleotide
1). This DNA sequence contained the end of one open reading
frame (ORF) and the start of a second ORF. To clone the
intact gene which had been interrupted by the Tn916 element,
an oligonucleotide complementary to the newly determined
sequence was prepared (Table 3, oligonucleotide 2) and a
32
P-labeled PCR product was generated. The PCR product
was then used to probe a lDASHII genomic library. Lambda
clones were identified and plaque purified. DNA from one
probe-positive l clone with a genomic insert of 9 kb was prepared, digested with NotI, and ligated into the low-copy-number vector pWSK30. A number of attempts were made, without
success, to clone the 9-kb genomic fragment into pWKS30.
Therefore, the l DNA was partially digested with Sau3A, and
4- to 9-kb fragments were ligated into BamHI-digested
pWSK30. The ligation mixture was transformed into E. coli
XL1-Blue, and clones containing inserts were identified on 5bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-Gal) plates.
Clones containing the insert of interest were identified by colony hybridization using the 32P-labeled PCR product as a
probe. The plasmid designated pRSM1494 was further characterized.
Characterization of pRSM1494. The DNA sequence of the
ORF interrupted by the Tn916 element in strain 1381 was
completely determined. This gene, designated losB, encodes a
protein with an Mr of 40,246. The derived amino acid sequence

FIG. 7. Partial restriction map of pRSM1640. The sequence begins with the
Sau3A/BamHI junction of the l clone. The positions and direction of transcription of the rpmE, losA, losB, and ethA genes are designated. The V marks the
insertion of the Tn916 element in the 1381 genomic DNA.

of the losB gene has homology to the product of the E. coli rfaK
gene (24% identity and 52% similarity). The rfaK gene is
thought to encode an N-acetylglucosamine glycosyltransferase
(18). Immediately 59 of the losB gene is a gene that we designated losA. The losA gene encodes a protein with an Mr of
25,795. The derived amino acid sequence of this gene has
homology to the lic2A gene of H. influenzae (15) and the lpsA
gene of Pasteurella haemolytica (38). Both of these genes are
thought to encode proteins involved in LOS (or lipopolysaccharide) biosynthesis. 59 to the losA gene is an ORF which
encodes a peptide with an Mr of 7,917. This gene is the H.
ducreyi homolog of the rpmE gene, which encodes the ribosomal protein L31. The H. ducreyi protein is 91% identical to
the H. influenzae protein. 39 to the losB gene is the H. ducreyi
homolog of the ethA gene, which encodes exonuclease III.
This gene is transcribed in the opposite direction; the stop
codon is located at nucleotides 2187 to 2189. A partial map
of pRSM1494 is shown in Fig. 7.
Complementation of the Tn916 mutation in H. ducreyi 1381.
To complement the defect in strain 1381, we attempted to
clone the genomic insert from the l clone as a NotI fragment
into the shuttle vector pLS88 which had been modified by the
addition of NotI restriction site (32). We were unable to clone
the NotI fragment into pLS88 and therefore amplified the losB
gene by PCR using oligonucleotides 3 and 4 (Table 3). The
PCR product was cloned into pCRII, and then the EcoRI
fragment containing the PCR product was cloned into EcoRIdigested pLS88. A clone with the appropriate restriction map
was identified and designated pRSM1640. The EcoRI site is
located immediately 39 to the Strr gene of pLS88, and thus the
promoter for the Strr gene may be responsible for transcription
of the losB gene in pRSM1640. Plasmids pRSM1640 and
pLS88 were transformed into strain 1381. LOS was isolated
from strain 1381/pRSM1640. It had the same SDS-PAGE profile as strain 35000, indicating that the losB gene is sufficient to
complement the mutation in strain 1381 (Fig. 8). LOS from
this strain was also reactive with MAb 3F11 (data not shown).

FIG. 8. Silver-stained SDS-polyacrylamide gel of LOS preparations demonstrating complementation of the mutation in strain 1381. The losB gene was
amplified by PCR, and the amplicon was cloned into the EcoRI site of the shuttle
vector pLS88 to form pRSM1640. LOS was isolated from each strain, subjected
to SDS-PAGE, and silver stained. Lane A, LOS from strain 1381; lane B, LOS
from strain 1381/pRSM1640; lane C, LOS from strain 1381/pLS88; lane D, LOS
from strain 35000.
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TABLE 4. Adherence to and invasion of keratinocytes
by strains 35000 and 1381
Strain

% Adherence
(mean 6 SD)

% Invasion
(mean 6 SD)

35000
1381
1381/pLS88
1381/pRSM1640

15 6 1.5
4.5 6 1
5.3 6 1.4
13.3 6 1.2

7.2 6 1.8
0.08 6 0.05
0.1 6 0.05
5.2 6 1.1

Strain 1381 fails to exhibit normal adherence to and invasion of normal human keratinocytes. Mid-log-phase H. ducreyi
cells were coincubated with human keratinocyte monolayers
for 2 h. Nonadherent bacteria were removed by washing, and
the number of adherent bacteria was determined as described
previously (7). Under these conditions, 15% of the CFU of
strain 35000 put into the coculture were adherent. In contrast,
approximately 5% of strain 1381 cells were adherent. Complementation of the Tn916 mutation in 1381 with pRSM1640
restored the adherent phenotype (Table 4). Similarly, in a
gentamicin protection assay, the invasive capability of strain
35000 was abolished by the losB mutation in strain 1381, and
the invasive phenotype was restored by complementation with
pRSM1640.
DISCUSSION
Transposon Tn916 and the related transposon Tn1545D3
have proven to be powerful tools for the construction of mutants of H. ducreyi. We and others have previously identified
mutants deficient in hemolysin (32, 54), hemoglobin binding
protein (51), and LOS biosynthetic genes (51) by using these
genetic elements. In this study, we used Tn916 mutagenesis to
identify a mutant deficient in the D-glycero-D-manno-heptose
heptosyltransferase. Immunologic screening was performed
with two murine MAbs of different isotypes, using different
isotype-specific detection reagents. Colonies which stained red
had lost the 3F11 binding specificity, while colonies which
stained purple retained the 3F11 binding specificity, greatly
simplifying the identification of the LOS mutants. One mutant
lacking the 3F11 epitope was characterized in detail. The major glycoform of the LOS produced by this strain, designated
1381, lacked residues distal to the single glucose extending off
heptose-I. In the wild-type strain, this glucose is linked to
D-glycero-D-manno-heptose, which is further extended by a trior tetrasaccharide that contains the terminal N-acetyllactosamine (MAb 3F11 epitope) and sialyl-N-acetyllactosamine
epitopes (27, 29). Therefore, the defect contained in this mutant strain 1381 precludes the normal extension of the major
oligosaccharide branch through the inability to form the DDheptosyla1-6 linkage to glucose. This defect may also explain
the oligosaccharide species observed in the ESI-MS spectra of
the oligosaccharide fraction with a mass of 1,486 Da. As suggested earlier, this unexpected oligosaccharide species was
consistent with a full-length oligosaccharide but lacking one
heptose residue compared to the major wild-type structure
with a mass of 1,678 Da. Given that the defect in this mutant
is associated with the inability to add the branch DD-heptose to
glucose, such a species may arise from an alternative biosynthetic
pathway that skips this DD-heptose and goes on to form a lactoN-neotetraose branch, Galb134GlcNAcb133Galb134Glc--.
We have previously noted that the African strain 33921 is capable of bypassing the DD-heptose by forming GlcNAcb13
3Galb134Glc-- (27), as was the major LOS from a strain
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reported by Schweda et al. (46) that made a lactose disaccharide branch (Galb134Glc--) off the conserved triheptose core.
In Salmonella typhimurium, the heptose biosynthetic pathway has been characterized in detail (41). In Salmonella, Dglycero-D-manno-heptose is thought to be the precursor of
D-glycero-L-manno-heptose. Assuming that the biosynthetic
pathway is conserved in H. ducreyi, we conclude that the mutation responsible for the phenotype of strain 1381 is in the
gene encoding the D-glycero-D-manno-heptose heptosyltransferase. Our conclusion is also consistent with the weak homology observed between LosB and another glycosyltransferase,
the product of the E. coli rfaK gene.
The amount and distribution of PEA were also determined
in the LOS of strain 1381. The amount of PEA found in the
LOS of this mutant was greater than that previously found in
the LOS of the parental strain. In the mutant LOS, MS analysis
identified two distinct sites of nonstoichiometric PEA substitution, one on the lipid A and one on the phospho-Kdo. Surprisingly, no PEA was found to be substituted off the triheptose
core. Reexamination of the LOS from strain 35000 suggests
that the PEA-containing glycoforms also contain PEA on
phospho-Kdo (11a) but none on the lipid A or heptose, the
latter of which was presumed to be the site of attachment
based on the similarity in the structures of the H. influenzae
and H. ducreyi LOS cores. This additional PEA substitution
may underlie an adaptive mechanism for the mutant, which
now has a much smaller LOS and potentially less stable outer
membrane. We have recently reported on these modifications
in the LOS of H. ducreyi and H. influenzae (12), as have Masoud et al. (25) in their characterization of the LOS of H.
influenzae serotype b strain Eagan. It is interesting that substitution of phosphate on lipid A has also been found in the LOS
of S. typhimurium (14), Neisseria meningitidis (20), and Moraxella catarrhalis (17, 26). In S. typhimurium, this lipid A alteration is the result of a mutation in a two-component regulatory
system which is thought to play a role in virulence (42).
Recent studies have demonstrated that H. ducreyi can adhere to and invade some eucaryotic cell lines. However, the
actual mechanism and the bacterial components involved in
this activity have not been defined. In 1993, Lagergard and
coworkers noted that H. ducreyi cells could withstand treatment at 56°C for 30 min without losing the ability to adhere to
HEp-2 cells (22). Some binding was observed after treatment
of the H. ducreyi cells at 100°C for 30 min. This finding implicated a heat-stable structure, possibly LOS, in the binding of
H. ducreyi to HEp-2 cells. Subsequently, Brentjens et al. demonstrated that H. ducreyi can adhere to human keratinocytes,
cells which would be in contact with H. ducreyi early in the
infectious process (7). In this study, we have demonstrated that
the Tn916 mutant, defective in LOS biosynthesis, has a markedly reduced ability to adhere to and invade human keratinocytes compared to the parental strain. As described above, this
defect in the heptosyltransferase resulted in a truncated LOS
structure which lacks the terminal Galb1-4GlcNAcb1-3Gal
epitope, a structure present on the LOS of 97% of H. ducreyi
strains as determined by MAb 3F11 binding (9a). This finding
implies that this terminal LOS region is involved in attachment
and possibly invasion. There is precedence for this finding, as
recently reported data implicate LOS (or rough lipopolysaccharide) as an important attachment ligand for other human
pathogens (33, 37, 44, 60). Of particular relevance are the data
reported by Schwan et al. (44) demonstrating that the terminal
portion of the LOS expressed by many strains of N. gonorrhoeae is important for attachment and invasion of certain
eucaryotic cells. Interestingly, we have previously shown that
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the major LOS glycoform of H. ducreyi is very similar to a LOS
glycoform expressed by most gonococci (29).
While the mechanism(s) of bacterial adherence and invasion
of host cells is most certainly a multifactorial event, our data
show that the terminal oligosaccharide portion of the LOS is
involved in at least one form of attachment to human keratinocytes in vitro. This is a particularly important observation
considering that in natural infection, the portal of entry for H.
ducreyi is most likely a break in the epithelium generated
during sexual intercourse (1, 30). Recent studies using an experimental human challenge model of H. ducreyi infection
have demonstrated that a disruption in the continuity of the
cornified layer of the skin is critical for establishment of infection (50). While it is difficult to compare our in vitro data with
the actual mechanisms occurring in vivo, it is reasonable to
predict that human keratinocytes are likely the first host cells
encountered by H. ducreyi. Therefore, attachment to these
cells may be one of the critical, early steps involved in the
pathogenesis of chancroid infections. The results presented in
this report implicate the terminal oligosaccharide region of H.
ducreyi LOS as a bacterial component involved in adherence
to, and invasion of, human keratinocytes in vitro. Our data
further illustrate that more detailed studies are needed to
provide a better understanding of the role of LOS structure as
it pertains to H. ducreyi infection.
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ADDENDUM
While this paper was under review, a report by Stevens et al.
was published (51a). This report characterizes the same gene
cluster and evaluates the virulence of strains with LOS mutations in the chilled rabbit model.
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